missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ OXR1 Polyclonal Antibody

Description
Recommended positive controls: NT2D1, IMR32, U87-MG, MCF-7. Predicted reactivity: Mouse (90%), Rat (89%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the peptidase T1A family, that is a 20S core alpha subunit. Two alternative transcripts encoding different isoforms have been identified.
Spécification
Spécification
| Antigène | OXR1 |
| Applications | Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugué | Unconjugated |
| Formule | PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 |
| Expression | OXR1 |
| Numéro d’ordre du gène | Q8N573 |
| Alias de gène | 2210416C20Rik; C7; C7B; Gm1238; Nbla00307; nucleolar protein C7; oxidation resistance 1; oxidation resistance protein 1; Oxr1; Protein C7; putative protein product of Nbla00307; TBC/LysM-associated domain containing 3; TLDC3 |
| Symboles de gène(s) | OXR1 |
| Afficher plus |
Nom du produit
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?